List of Excipients in API VORASIDENIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing VORASIDENIB
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Servier Pharmaceuticals LLC | VORANIGO | vorasidenib | 72694-879 | CELLULOSE, MICROCRYSTALLINE | 2031-08-06 |
| Servier Pharmaceuticals LLC | VORANIGO | vorasidenib | 72694-879 | CROSCARMELLOSE SODIUM | 2031-08-06 |
| Servier Pharmaceuticals LLC | VORANIGO | vorasidenib | 72694-879 | FERROSOFERRIC OXIDE | 2031-08-06 |
| Servier Pharmaceuticals LLC | VORANIGO | vorasidenib | 72694-879 | HYPROMELLOSE | 2031-08-06 |
| Servier Pharmaceuticals LLC | VORANIGO | vorasidenib | 72694-879 | LACTOSE MONOHYDRATE | 2031-08-06 |
| Servier Pharmaceuticals LLC | VORANIGO | vorasidenib | 72694-879 | MAGNESIUM STEARATE | 2031-08-06 |
| Servier Pharmaceuticals LLC | VORANIGO | vorasidenib | 72694-879 | POLYETHYLENE GLYCOL | 2031-08-06 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for VORASIDENIB
Excipient focus: CELLULOSE, MICROCRYSTALLINE
VORASIDENIB drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
VORASIDENIB drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
VORASIDENIB drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
VORASIDENIB drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
VORASIDENIB drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
VORASIDENIB drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
VORASIDENIB drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
VORASIDENIB drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
VORASIDENIB drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
VORASIDENIB drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
VORASIDENIB drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceuticals LLC | vorasidenib | 72694-879 |
| >Company | >Ingredient | >NDC |
VORASIDENIB drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch